About Lysosome-associated membrane glycoprotein 2
Lysosome-associated membrane glycoprotein 2 (LAMP2) is a protein
from Homo sapiens identified by UniProt accession
P13473, 410 residues long.
MolForge cross-references it against 0 known binders and
485 disease associations.
Target properties
| Protein name | Lysosome-associated membrane glycoprotein 2 |
| UniProt accession | P13473 |
| Gene | LAMP2 |
| Organism | Homo sapiens |
| Length | 410 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (485)
Diseases linked to this target (Open Targets).
- Glycogen Storage Disease Type 2b · score 0.83
- hypertrophic cardiomyopathy · score 0.54
- Abnormality of the cardiovascular system · score 0.54
- dilated cardiomyopathy · score 0.49
- cardiomyopathy · score 0.49
- Pigmentary retinopathy · score 0.37
- isolated noncompaction of the ventricular myocardium · score 0.34
- familial hypertrophic cardiomyopathy · score 0.31
- breast adenocarcinoma · score 0.25
- Intellectual disability · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P13473-F1 | alphafold | PREDICTED | 83.17 | — |
Amino-acid sequence (410 residues)
MVCFRLFPVP GSGLVLVCLV LGAVRSYALE LNLTDSENAT CLYAKWQMNF TVRYETTNKT YKTVTISDHG TVTYNGSICG DDQNGPKIAV QFGPGFSWIA NFTKAASTYS IDSVSFSYNT GDNTTFPDAE DKGILTVDEL LAIRIPLNDL FRCNSLSTLE KNDVVQHYWD VLVQAFVQNG TVSTNEFLCD KDKTSTVAPT IHTTVPSPTT TPTPKEKPEA GTYSVNNGND TCLLATMGLQ LNITQDKVAS VININPNTTH STGSCRSHTA LLRLNSSTIK YLDFVFAVKN ENRFYLKEVN ISMYLVNGSV FSIANNNLSY WDAPLGSSYM CNKEQTVSVS GAFQINTFDL RVQPFNVTQG KYSTAQDCSA DDDNFLVPIA VGAALAGVLI LVLLAYFIGL KHHHAGYEQF
Explore Lysosome-associated membrane glycoprotein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets